Skip to main content
Clinical Trials/NCT06217679
NCT06217679
Completed
Not Applicable

Comparing the Effects of Different Types of Exercise on Glucose Handling and Muscle Metabolism in Young Males and Females

University of Waterloo1 site in 1 country24 target enrollmentMay 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glycemic Control
Sponsor
University of Waterloo
Enrollment
24
Locations
1
Primary Endpoint
Blood insulin change
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the proposed study is to compare the acute effects of different types of exercise modalities on glucose handling in young, healthy males and females. The exercise modalities that will be compared include: a high intensity interval exercise (HIIE) protocol, a moderate intensity continuous exercise (MICE) protocol and a low-load, high-repetition (LL-HR) resistance exercise protocol.

Detailed Description

The purpose of this study is to compare the effects of different exercise modalities (High intensity interval exercise, Moderate intensity continuous exercise, and Low-load-high repetition resistance exercise) on blood sugar control in young healthy, males and females. To test this theory, a sugar challenge (oral glucose tolerance test - OGTT) will be performed during the pre-testing visit to determine the baseline blood sugar response. An OGTT will also be performed 2 hours after each single exercise session to determine how each type of exercise affects the blood sugar response. Investigators will take multiple blood samples throughout the trial to allow us to measure blood sugar, insulin and concentrations and oxidative stress. Muscle biopsies will be taken before and after each exercise bout so that investigators can examine the underlying mechanisms that contribute to the effectiveness of the different types of exercise on blood sugar control. Investigators will also use an ultrasound to measure factors related to of cardiovascular health such as artery stress and vascular conductance during the exercise bouts. Direct benefits of this study include characterizing sex differences of blood sugar handling after single exercise sessions. This study could have direct benefits on deterring the effectiveness of different forms of exercise on blood sugar levels.

Registry
clinicaltrials.gov
Start Date
May 1, 2018
End Date
October 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • In order to participate in this study, participants must be a healthy man or woman between the ages of 18 and 30 years.

Exclusion Criteria

  • Presence of chronic health condition(s) \[i.e. metabolic (i.e. Type 1 or type 2 diabetes), cardiovascular (i.e hypertension), respiratory (i.e. chronic pulmonary obstructive disorder) or digestive (i.e. ulcerative colitis) disorders.
  • Are pregnant, or suspect that they may be pregnant, or nursing
  • Inability to complete the single exercise sessions.
  • Regularly participate in cardiovascular (\>3 sessions/week) or resistance training (\>2 sessions/week) exercise.
  • Have an allergy to local anesthetic (or family history of allergy)
  • Have undergone a barium swallow or an infusion of a contrast agent in the past 3 weeks
  • Are taking prescription anti-coagulant or anti-platelet medications (e.g., warfarin, heparin, clopidogrel)
  • Inability to exercise as suggested by the get active questionnaire (GAQ)
  • BMI \> 27 kg/m2

Outcomes

Primary Outcomes

Blood insulin change

Time Frame: 120mins

To assess the effect of sex and exercise on basal and post-exercise blood insulin

Insulin sensitivity change

Time Frame: 120mins

Assess the changes in insulin sensitivity pre to post exercise

Blood glucose change

Time Frame: 120mins

To assess the effect of sex and exercise on basal and post-exercise blood glucose.

Blood c-peptide change

Time Frame: 120mins

To assess the effect of sex and exercise on basal and post-exercise blood c-peptide.

Secondary Outcomes

  • TBC1 domain family member 1 change (TBC1D1)(35mins)
  • protein kinase B change(35mins)
  • TBC1 domain family member 4 change (TBC1D4)(35mins)
  • estrogen concentration(30mins)
  • progesterone concentration(30mins)
  • 5' adenosine monophosphate-activated protein kinase change(35mins)
  • glucose transporter 4 change (GLUT4)(35mins)

Study Sites (1)

Loading locations...

Similar Trials